Filterlex Medical

Embolic Protection Device

Health Tech & Life Sciences
Active
Series A Caesarea Founded 2015
Total raised
$19.5M
Last: Undisclosed 2024-07
Stage
Series A
Founded
2015
Headcount
7
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Filterlex Medical is a medical device start-up developing the Captis, a full-body embolic protection device that can be easily and intuitively deployed and retrieved. The device is securely positioned in the aorta and protects its surface while facilitating a seamless TAVI procedure. Its distinctive, triple-action design provides full-body embolic protection by deflecting, capturing, and removing embolic particles. It requires no additional access and does not interfere with the procedure workflow.

Funding history · 5 rounds · $19.5M total

2024-07
Undisclosed Undisclosed
2021-12
Undisclosed $7.0M
2021-11
Series A $6.0M
2019-07
Series A $3.0M
2016-06
Seed $900K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

preventionhospitalscardiovascularcardiologystrokesurgeryclinicsdoctorshealthcare-providerscathetersmedical-devices